talazoparib plus enzalutamide clinical trials

Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPC

This study is for men with a certain type of advanced prostate cancer (mCSPC) that has spread and has specific gene changes. It compares a new drug called talazoparib, given with standard treatment enzalutamide, against enzalutamide alone, to see if it's safe and effective.